Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Lipid research Laboratory

Faculty of Medicine

Technion

Rambam Medical Center

Israel

Name/email consistency: high

Lipid research Laboratory, Faculty of Medicine, Technion, Rambam Medical Center, Israel. 2004 - 2007
The Lipid Research Laboratory, The Bruce Rappaport Faculty of Medicine, Technion, The Rappaport Family Institute for Research in the Medical Sciences and Rambam Medical Center, Israel. 2002 - 2005

Macrophage NADPH oxidase activation, impaired cholesterol fluxes, and increased cholesterol biosynthesis in diabetic mice: a stimulatory role for D-glucose. Hayek, T., Kaplan, M., Kerry, R., Aviram, M. Atherosclerosis (2007) [Pubmed]
Macrophage foam-cell formation in streptozotocin-induced diabetic mice: stimulatory effect of glucose. Hayek, T., Hussein, K., Aviram, M., Coleman, R., Keidar, S., Pavoltzky, E., Kaplan, M. Atherosclerosis (2005) [Pubmed]
Omapatrilat decreased macrophage oxidative status and atherosclerosis progression in atherosclerotic apolipoprotein E-deficient mice. Hayek, T., Hamoud, S., Keidar, S., Pavlotzky, E., Coleman, R., Aviram, M., Kaplan, M. J. Cardiovasc. Pharmacol. (2004) [Pubmed]
Tissue angiotensin-converting-enzyme (ACE) deficiency leads to a reduction in oxidative stress and in atherosclerosis: studies in ACE-knockout mice type 2. Hayek, T., Pavlotzky, E., Hamoud, S., Coleman, R., Keidar, S., Aviram, M., Kaplan, M. Arterioscler. Thromb. Vasc. Biol. (2003) [Pubmed]
Ramipril administration to atherosclerotic mice reduces oxidized low-density lipoprotein uptake by their macrophages and blocks the progression of atherosclerosis. Hayek, T., Kaplan, M., Raz, A., Keidar, S., Coleman, R., Aviram, M. Atherosclerosis (2002) [Pubmed]